Results 261 to 270 of about 120,591 (296)

Harm reduction and the medicalisation of tobacco use

Sociology of Health & Illness, 2012
AbstractIn tobacco control the focus has, for some time, been on abstinence from all types of tobacco use as the only solution to the problem of smoking, and harm reduction approaches are controversial. The most recent English tobacco strategy has incorporated harm reduction approaches in the form of new ‘routes’ to quitting smoking that encourage ...
openaire   +2 more sources

Harm Reduction in Tobacco Control-does it reduce harm?

Drugs: Education, Prevention and Policy, 1998
‘Harm reduction’ is now discussed as a new strategy for tobacco control. The strategy can, however, be pursued in several different ways. Some of those may reduce harm for the individual concerned, but might-at the same time-eventually not reduce the total harm done, from a public health point of view.
openaire   +1 more source

Oral cancer and tobacco: developments in harm reduction

British Dental Journal, 2018
Oral squamous cell carcinoma is associated with the use of tobacco products. The predominant addictive substance in tobacco is nicotine, however, the major carcinogenic substances are in the other components of the tobacco leaf. The highest risk from tobacco use arises from combustion in the form of cigarettes.
openaire   +2 more sources

Smokeless Tobacco as a Nicotine Delivery Device: Harm or Harm Reduction?

Clinical Pharmacology & Therapeutics, 2011
Smokeless tobacco (ST) delivers nicotine in doses similar to those received in cigarette smoking but does not expose the user to the toxic combustion gases and particles that are responsible for most tobacco-induced disease. This Opinion piece discusses the controversies pertaining to ST and health, the pros and cons of ST in harm reduction, and ...
openaire   +2 more sources

Swedish snus for tobacco harm reduction

The Lancet, 2007
Martin, McKee, Anna, Gilmore
openaire   +4 more sources

[Harm reduction strategy in tobacco control].

Epidemiologia e prevenzione, 2012
Potentially reduced exposure products (PREPs), already sold in USA and in some European Countries, are low-nitrosamine cigarettes, low-nitrosamine smokeless tobacco (e.g., the Swedish Snus), cigarette-like products, and medicinal nicotine products. Even e-cigarette delivers nicotine.
openaire   +1 more source

Dissent over harm reduction for tobacco

The Lancet, 2006
Nigel, Gray, Jack, Henningfield
openaire   +2 more sources

Tobacco harm reduction

2010
Dorothy Hatsukami, Mark Parascandola
openaire   +1 more source

Transdisciplinarity Among Tobacco Harm–Reduction Researchers

American Journal of Preventive Medicine, 2008
Keith G. Provan, Pamela I. Clark, Timothy Huerta   +2 more
openaire   +1 more source

Adding harm reduction to tobacco control

The Lancet, 2007
openaire   +2 more sources